Stroke Trials Registry

Eptifibatide

Action
Antiplatelet agent. Glycoprotein IIb/IIIa antagonist.

Status
Approved for use with acute coronary syndromes. Open label trial of 10 patients undergoing carotid angioplasty and stent placement found intravenous eptifibatide to be safe.

Trial(s)
= Ongoing
= Completed

CATALIST Combination Anti-platelet and Anti-coagulation Treatment After Lysis of Ischemic Stroke Trial [SPOTRIAS]

CLEAR Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke [SPOTRIAS]

Safety of intravenous eptifibatide in patients undergoing internal carotid angioplasty and stent placement

Web Links and Publications

COR Therapeutics, Inc. Web Site.

Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement.
Neurosurgery 2001 May;48(5):998-1004.

UID: 156